oxybutynin has been researched along with Breakthrough Pain in 3 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Breakthrough Pain: Acute pain that comes on rapidly despite the use of pain medication.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment directed towards painful metastases must be considered." | 2.66 | Breakthrough cancer pain in 2020. ( Klepstad, P; Løhre, ET; Thronæs, M, 2020) |
| "The recommended dosing interval for transdermal fentanyl is every 72 h." | 1.43 | A new once-a-day fentanyl citrate patch (Fentos Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch. ( Hirayama, Y; Horiuchi, I; Ishitani, K; Kato, J; Koike, K; Kusakabe, T; Machino, T; Mihara, H; Nagasako, T; Nishisato, T; Terui, T; Yamakage, M, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Løhre, ET | 1 |
| Thronæs, M | 1 |
| Klepstad, P | 1 |
| Mercadante, S | 1 |
| Masedu, F | 1 |
| Valenti, M | 1 |
| Aielli, F | 1 |
| Koike, K | 1 |
| Terui, T | 1 |
| Nagasako, T | 1 |
| Horiuchi, I | 1 |
| Machino, T | 1 |
| Kusakabe, T | 1 |
| Hirayama, Y | 1 |
| Mihara, H | 1 |
| Yamakage, M | 1 |
| Kato, J | 1 |
| Nishisato, T | 1 |
| Ishitani, K | 1 |
1 review available for oxybutynin and Breakthrough Pain
| Article | Year |
|---|---|
Breakthrough cancer pain in 2020.
Topics: Analgesics, Opioid; Breakthrough Pain; Cancer Pain; Fentanyl; Humans; Neoplasm Metastasis; Pain Mana | 2020 |
1 trial available for oxybutynin and Breakthrough Pain
| Article | Year |
|---|---|
Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
Topics: Administration, Intranasal; Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Breakthr | 2019 |
1 other study available for oxybutynin and Breakthrough Pain
| Article | Year |
|---|---|
A new once-a-day fentanyl citrate patch (Fentos Tape) could be a new treatment option in patients with end-of-dose failure using a 72-h transdermal fentanyl matrix patch.
Topics: Administration, Cutaneous; Aged; Analgesics, Opioid; Breakthrough Pain; Cross-Sectional Studies; Fem | 2016 |